Holding of 2026 Q1 Earnings Conference Call (IR)
-
Holding an online IR session on May 26, 2026 at 4:00 PM for 2026 Q1 earnings release and business update
-
Main content: 2026 Q1 earnings review, key business status and outlook, Q&A session
-
Target: Investors, securities analysts, etc.
-
IR materials will be posted on KRX KIND system and company website
KOSDAQ Filing Information
-
Filing: Holding of Investor Relations Conference (IR)
-
Company: Optipharm (153710)
-
Submission: Optipharm.CO.,LTD
-
Receipt: 05-20-2026
-
Under KRX KOSDAQ Market Division